MKP-1 modulating agents such as rosiglitazone and triptolide were used to demonstrate MKP-1's role in tumorigenesis.
Although upregulation of MDR1/P-glycoprotein may be observed for a median period of 4 months after therapy with modulating agents such as anthracyclines or taxanes (M Filipits, personal communication), there is no evidence in the literature that the cellular uptake of FU and fluoropyrimidine nucleosides is influenced by the expression of MDR1/P-glycoprotein.
Previous studies showed that monotherapy with ECP produces an overall response rate of approximately 60%, while clinical data support that ECP is much more effective when combined with other immune modulating agents such as interferons or retinoids, or when used as consolidation treatment after total skin electron beam irradiation.
Clinical efficacy of immune modulating agents, such as methotrexate [ 48] and infliximab [ 49], implicates chronic inflammation being secondary to an immune-mediated process.
A number of chemicals have been reported to improve the reprogramming efficiency (reviewed by Li et al. ), including several epigenetic modulating agents, such as VPA, 5′-AZA and BIX-01294, and several major signaling pathway inhibitors, such as CHIR99021, PD0325901 and TGFβ receptor inhibitors.
Recent evidence also shows that the uses of immune-modulating agents such as statins, ACE inhibitors or glucocorticoids modulate the course of AF. 39 In addition to CRP, b-type natriuretic peptide (BNP) has been shown to be an indicator of new onset AF and AF recurrence after successful cardioversion.
A common approach for the inhibition of oxidant-mediated injury is the use of glutathione-modulating agents such as sulfhydryl or thiol compounds.
Because autophagy-modulating agents such as rapamycin and chloroquine have already been used clinically to treat cancer, it is conceivable that targeting autophagic pathways may provide a new opportunity for discovery and development of more novel cancer therapeutics.
Several modulating agents to prevent nephrotoxicity, such as thiosulphate (Leeuwenkamp et al, 1991), diethyldithiocarbamate (Gandara et al, 1995; Paredes et al, 1988), glutathione (Smyth et al, 1997), amifostine (Kemp et al, 1996; Hartmann et al, 2000) and mesna (Leeuwenkamp et al, 1991; Hausheer et al, 1998; Boven et al, 2002), have been investigated.
Therefore, foreseen future trends lay in the benefit of applying the reviewed P-gp modulating agents into conventional delivery systems such as matrix tablets, which offer the added advantages of ease of administration, cost effectiveness, and improved patient compliance to treatment plans as it is a conventional method of drug delivery with a wide array of applications.
Preventing the beginning of inflammatory systemic cascade by means of LPS modulating agents might have a valuable effect in the control of such deadly illness.
